Discontinued — last reported Q3 '25
Equity
Common Stock
Roivant Sciences Common Stock decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ3 2025
How to read this metric
An increase indicates the issuance of new shares, which may dilute existing shareholders, while a stable balance indicates no new equity financing.
Detailed definition
This represents the aggregate par value of all common shares issued and outstanding. It is the foundational equity layer...
Peer comparison
Standard equity line item for all publicly traded companies.
Metric ID:
common_stockHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $100.00B | $7.00B | $7.00B | $0.00 | $7.00B | $7.00B | $7.00B | $0.00 | $7.00B | $7.00B | $7.00B | $0.00 | $7.00B | $7.00B | $7.00B | $0.00 | $7.00B | $7.00B | $7.00B | $0.00 |
| QoQ Change | — | -93.0% | +0.0% | -100.0% | — | +0.0% | +0.0% | -100.0% | — | +0.0% | +0.0% | -100.0% | — | +0.0% | +0.0% | -100.0% | — | +0.0% | +0.0% | -100.0% |
| YoY Change | — | — | — | — | -93.0% | +0.0% | +0.0% | — | +0.0% | +0.0% | +0.0% | — | +0.0% | +0.0% | +0.0% | — | +0.0% | +0.0% | +0.0% | — |
Range$0.00 – $100.00B
CAGR-100.0%
Avg YoY Growth-7.8%
Median YoY Growth+0.0%
Common Stock at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's common stock?
- Roivant Sciences (ROIV) reported common stock of $0.00 in Q1 2026.
- What does common stock mean?
- The total par value of all common shares issued to shareholders.